Emme Closes $2.5M Seed Round

Funding Rounds

▤ Summary

The firms founding partner, Christine Aylward, joined the board, along with experienced healthcare innovator and Evidation CEO Deborah Kilpatrick. "Emme is the first company to offer a comprehensive and complete birth control solution," said Christine Aylward, Founder and Managing Partner of Magnetic Ventures. Motivated to solve this pressing healthcare issue, Amanda French and Janene Fuerch, MD, co-founded Emme in 2017 during their fellowship at Stanford Byers Center for Biodesign. They also disrupt hormone balance causing side effects such as bleeding, nausea, mood changes, and headaches," French shared. Their first product, the Emme Smart Case and app, is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills.

$ Funding

$
Amount $2.5M Total raised
□
Date August 27, 2020 Announcement date
◎
Investors - Lead investors
▥
Company https://www.meetemme.com/ Funded company

▥ Classifications

industries
HealthTech
applications
Engineering & Scientific

◇ AskAI Classifications

Labels
Healthcare Software SaaS Medical Practice Management

▦ Linked Companies

Emme
up to $1M